These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2856504)

  • 1. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
    Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
    Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
    Christensen C
    Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
    Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
    Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
    Christensen C
    Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
    Juby LD; Burke DA; Axon AT
    Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome.
    Brunani A; Crespi C; De Martin M; Dubini A; Piolini M; Cavagnini F
    J Endocrinol Invest; 1991 Sep; 14(8):685-9. PubMed ID: 1663530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours.
    Lamberts SW; Pieters GF; Metselaar HJ; Ong GL; Tan HS; Reubi JC
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):561-6. PubMed ID: 2849276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
    Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
    Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
    Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
    Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
    Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
    Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
    Scheffold N; Arnold R; Cyran J
    Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of the watery diarrhea-hypokalemia-achlorhydria syndrome: successful preoperative treatment of watery diarrhea with a somatostatin analogue.
    Yoshioka M; Sakazume M; Fukagawa M; Seki T; Honma K; Uchida K; Yoshida K; Miyake Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Sep; 19(3):294-8. PubMed ID: 2554028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
    Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
    Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term treatment of a VIPoma with somatostatin analogue in advance of curative operation].
    Yoshioka M; Sakazume M; Fukagawa M; Seki T
    Nihon Naika Gakkai Zasshi; 1988 Aug; 77(8):1276-7. PubMed ID: 2853716
    [No Abstract]   [Full Text] [Related]  

  • 16. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
    Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
    Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
    Maton PN; Gardner JD; Jensen RT
    Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
    Clements D; Elias E
    Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.
    Antonelli A; Gambuzza C; Bertoni F; Baschieri L
    J Endocrinol Invest; 1993 Jan; 16(1):57-9. PubMed ID: 8383153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
    Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
    Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.